Decoding the Contribution of IAPP Amyloid Aggregation to Beta Cell Dysfunction: A Systematic Review and Epistemic Meta-Analysis of Type 1 Diabetes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020767 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Valeria Moya-Gudiño und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación en Enfermedades Metabólicas, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexic…. Hauptthemen laut MEDLINE: Islet Amyloid Polypeptide, Diabetes Mellitus, Type 1, Insulin-Secreting Cells, Amyloid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes Mellitus Type 1 (DM1) is an autoimmune disease characterized by the destruction of beta cells in the pancreas. Although amyloid formation has been well-studied in Diabetes Mellitus Type 2 (DM2), its role in DM1 remains unclear. Understanding how islet amyloid polypeptide (IAPP) contributes to beta cell dysfunction and death in DM1 could provide critical insights into disease mechanisms and pave the way for novel diagnostic and therapeutic strategies. A systematic review and epistemic meta-analysis was conducted using a modified PICO framework, focusing on studies related to DM1 and the IAPP aggregation process. Searches in PubMed, BIREME, and Web of Science yielded 37 relevant articles, which were analyzed and individually evaluated based on specific quality criteria. Studies that experimentally identified the formation of IAPP oligomers in DM1 were selected, along with relevant review articles. Experimental studies from human and animal models detected the presence of IAPP oligomers in DM1 patients, as well as in nonobese diabetic (NOD) and homozygous mice. Techniques like Western Blot (WB), Transmission Electron Microscopy (TEM) and Congo red staining detected various oligomers sizes, with smaller ones showing higher cytotoxicity. IAPP oligomers have been detected in the pancreatic islets of DM1 patients, contributing to beta cell damage and disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Investigación en Enfermedades Metabólicas, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.
- Servicio de Endocrinología, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
ORCID-Profile: Cristina Revilla-Monsalve, Myriam M Altamirano-Bustamante
Zitieren
APA
Moya-Gudiño, V., Altamirano-Bustamante, N. F., Revilla-Monsalve, C., & Altamirano-Bustamante, M. M. (2025). Decoding the Contribution of IAPP Amyloid Aggregation to Beta Cell Dysfunction: A Systematic Review and Epistemic Meta-Analysis of Type 1 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020767
Vancouver
Moya-Gudiño V, Altamirano-Bustamante NF, Revilla-Monsalve C, Altamirano-Bustamante MM. Decoding the Contribution of IAPP Amyloid Aggregation to Beta Cell Dysfunction: A Systematic Review and Epistemic Meta-Analysis of Type 1 Diabetes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020767
BibTeX
@article{MoyaGudio2025,
author = {Moya-Gudiño, Valeria and Altamirano-Bustamante, Nelly F and Revilla-Monsalve, Cristina and Altamirano-Bustamante, Myriam M},
title = {Decoding the Contribution of IAPP Amyloid Aggregation to Beta Cell Dysfunction: A Systematic Review and Epistemic Meta-Analysis of Type 1 Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020767}
}
EUVIMED